Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Incomplete immune reconstitution despite virologic suppression in HIV-1 infected children and adolescents.

Krogstad P, Patel K, Karalius B, Hazra R, Abzug MJ, Oleske J, Seage GR 3rd, Williams PL, Borkowsky W, Wiznia A, Pinto J, Van Dyke RB; Pediatric HIVAIDS Cohort Study, IMPAACT 219C, and NICHD International Site Development Initiative (NISDI) Investigators.

AIDS. 2015 Mar 27;29(6):683-93. doi: 10.1097/QAD.0000000000000598.

2.

Immunological failure despite virological suppression in HIV seropositive individuals on antiretroviral therapy.

Prabhakar B, Banu A, Pavithra HB, Chandrashekhara P, Sasthri S.

Indian J Sex Transm Dis. 2011 Jul;32(2):94-8. doi: 10.4103/0253-7184.85412.

3.

Treatment-mediated alterations in HIV fitness preserve CD4+ T cell counts but have minimal effects on viral load.

Vaidya NK, Rong L, Marconi VC, Kuritzkes DR, Deeks SG, Perelson AS.

PLoS Comput Biol. 2010 Nov 24;6(11):e1001012. doi: 10.1371/journal.pcbi.1001012.

4.

Patients with discordant responses to antiretroviral therapy have impaired killing of HIV-infected T cells.

Natesampillai S, Nie Z, Cummins NW, Jochmans D, Bren GD, Angel JB, Badley AD.

PLoS Pathog. 2010 Nov 24;6(11):e1001213. doi: 10.1371/journal.ppat.1001213.

5.

Factors associated with HIV testing history and HIV-test result follow-up among female sex workers in two cities in Yunnan, China.

Xu J, Brown K, Ding G, Wang H, Zhang G, Reilly K, Li Q, Wang G, Wang N.

Sex Transm Dis. 2011 Feb;38(2):89-95. doi: 10.1097/OLQ.0b013e3181f0bc5e.

6.

Microbial translocation induces persistent macrophage activation unrelated to HIV-1 levels or T-cell activation following therapy.

Wallet MA, Rodriguez CA, Yin L, Saporta S, Chinratanapisit S, Hou W, Sleasman JW, Goodenow MM.

AIDS. 2010 Jun 1;24(9):1281-90. doi: 10.1097/QAD.0b013e328339e228.

7.

Mortality associated with discordant responses to antiretroviral therapy in resource-constrained settings.

Tuboi SH, Pacheco AG, Harrison LH, Stone RA, May M, Brinkhof MW, Dabis F, Egger M, Nash D, Bangsberg D, Braitstein P, Yiannoutsos CT, Wood R, Sprinz E, Schechter M; ARTLINC of IeDEA.

J Acquir Immune Defic Syndr. 2010 Jan;53(1):70-7. doi: 10.1097/QAI.0b013e3181c22d19.

8.

HIV replication capacity is an independent predictor of disease progression in persons with untreated chronic HIV infection.

Goetz MB, Leduc R, Wyman N, Kostman JR, Labriola AM, Lie Y, Weidler J, Coakley E, Bates M, Luskin-Hawk R; Long Term Monitoring Study (CPCRA060) Terry Beirn Community Programs for Clinical Research on AIDS.

J Acquir Immune Defic Syndr. 2010 Apr 1;53(4):472-9. doi: 10.1097/QAI.0b013e3181cae480.

9.

Infection with different hiv subtypes is associated with CD4 activation-associated dysfunction and apoptosis.

Bousheri S, Burke C, Ssewanyana I, Harrigan R, Martin J, Hunt P, Bangsberg DR, Cao H.

J Acquir Immune Defic Syndr. 2009 Dec;52(5):548-52. doi: 10.1097/QAI.0b013e3181c1d456.

10.

Relationship between HIV coreceptor tropism and disease progression in persons with untreated chronic HIV infection.

Goetz MB, Leduc R, Kostman JR, Labriola AM, Lie Y, Weidler J, Coakley E, Bates M, Luskin-Hawk R; Long-Term Monitoring Study (CPCRA 060) and Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA).

J Acquir Immune Defic Syndr. 2009 Mar 1;50(3):259-66. doi: 10.1097/QAI.0b013e3181989a8b. Erratum in: J Acquir Immune Defic Syndr. 2009 May 1;51(1):110.

11.

Clinical significance of human immunodeficiency virus type 1 replication fitness.

Dykes C, Demeter LM.

Clin Microbiol Rev. 2007 Oct;20(4):550-78. Review.

12.

Modelling the impact of antiretroviral use in resource-poor settings.

Baggaley RF, Garnett GP, Ferguson NM.

PLoS Med. 2006 Apr;3(4):e124. Epub 2006 Mar 14.

13.
14.

Diminished replicative fitness of primary human immunodeficiency virus type 1 isolates harboring the K65R mutation.

Weber J, Chakraborty B, Weberova J, Miller MD, QuiƱones-Mateu ME.

J Clin Microbiol. 2005 Mar;43(3):1395-400.

Supplemental Content

Support Center